MBMihoko Bennett

Mihoko Bennett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mihoko Bennett has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular Mechanisms of Exosomes From Human iPSC‐Cardiomyocytes and Mesenchymal Stem Cells in Restoring the Injured Myocardium

    by Eileen Tzng, Nathan Bayardo, Gentaro Ikeda, Nirmal Vadgama, Hiroyuki Takashima, Jennifer Lyons, Hirotaka Ieki, Mihoko Bennett, Michael Snyder, Joseph C. Wu, et al.

    Background: Exosomes are extracellular vesicles 30 to 150 nm in size, mediating the paracrine effects of mesenchymal stem cells (MSCs) and induced pluripotent stem cell–derived cardiomyocytes (iCMs) when used to restore the injured myocardium. While both MSC‐ and iCM‐derived exosomes (MSC‐Exo, iCM‐Exo) improve cardiac function, their mechanisms of action remain incompletely understood. This study investigates the shared and distinct effects of iCM‐Exo and MSC‐Exo in a porcine ischemia–reperfusion injury model. Methods: Female Yorkshire swine underwent proximal left anterior descending artery occlusion with a catheter balloon to induce ischemia–reperfusion injury. Ten 500‐μL transendocardial injections delivered a total of 5×10 11 iCM‐Exo or MSC‐Exo into the peri‐infarct region. Cardiac function was assessed via MRI at weeks 2 and 4, while transcriptomic sequencing of peri‐infarct tissue alongside exosomal cargo were performed to elucidate molecular drivers of exosome influenced, post ischemic modulation of gene expression. Results: Cardiac MRI revealed that iCM‐Exo significantly improved left ventricular ejection fraction, myocardial viability, scar size, and ventricular remodeling compared with MSC‐Exo and PBS controls. Transcriptomic analysis revealed both shared and distinct gene expression patterns between the treatments. Shared pathways, including extracellular matrix remodeling and neurovascular integration, contributed to baseline cardiac improvement. Distinct pathways in iCM‐Exo treatment involved metabolic reorganization and cardiomyocyte‐specific processes, while MSC‐Exo emphasized structural stabilization and anti‐inflammatory responses. Conclusions: These findings highlight the complementary roles of iCM‐Exo and MSC‐Exo in myocardial repair with shared pathways contributing to baseline improvement and distinct pathways driving differences in efficacy. Future studies investigating the potential of combinatorial approaches may provide further insights into optimizing the therapeutic outcomes for patients with heart failure.


  • Open Access

    Association between 5-minute oxygen saturation and neonatal death and intraventricular hemorrhage among extremely preterm infants

    by Siyuan Jiang, Xin Cui, Anup Katheria, Neil N. Finer, Mihoko V. Bennett, Jochen Profit, Henry C. Lee

    Objective: To assess the relationship between 5-min oxygen saturation (SpO2) and outcomes in extremely preterm infants. Study design: This cohort study included infants ≤28 weeks’ gestation across nine hospitals from 2020 to 2022. Death and / or severe intraventricular hemorrhage (IVH) were compared between infants with 5-min SpO2 < 80% and 80–100% using Poisson regression models. Receiver Operating Characteristic (ROC) curve and optimal breakpoint analysis were used to estimate the optimal breakpoint of 5-min SpO2 in relation to outcomes. Result: Of 390 infants, 184 (47.2%) had 5-min SpO2 < 80%. A 5-min SpO2 < 80% was independently associated with increased risks of death and / or severe IVH, early death, and severe IVH. ROC analysis of 5-min SpO2 identified optimal breakpoint at 81–85%, above which no additional benefit in outcomes was observed. Conclusion: Our findings support the current recommendation of 5-min SpO2 target of ≥80% for extremely preterm infants.


  • Open Access

    Association between 5-minute Oxygen Saturation and Neonatal Death and Intraventricular Hemorrhage among Extremely Preterm Infants

    by Henry Lee, Siyuan Jiang, Xin Cui, Anup Katheria, Neiil Finer, Mihoko Bennett

    Objective To assess the relationship between 5-minute oxygen saturation (SaO₂) and outcomes in extremely preterm infants. Study Design: This cohort study included infants ≤ 28 weeks' gestation across nine hospitals from 2020 to 2022. Death and / or severe intraventricular hemorrhage (IVH) were compared between infants with 5-minute SaO2 < 80% and 80–100% using Poisson regression models. Two-piecewise segmented regression model was used to estimate breakpoint of 5-minute SaO₂ in relation to outcomes. Result Of 390 infants, 184 (47.2%) had 5-minute SaO₂ < 80%. A 5-minute SaO₂ < 80% was independently associated with increased risks of death and / or severe IVH, early death, and severe IVH. Analysis of SaO₂ as a continuous variable revealed a breakpoint at 80% (95% CI: 75–86%), above which no additional benefit in outcomes was observed. Conclusion Our findings support the current recommendation of 5-minute SaO₂ target of 80% for extremely preterm infants.

  • Open Access

    Necrotizing enterocolitis in infants born in Japan and born to Japanese mothers in California: a retrospective cohort study

    by Satoshi Kusuda, Mihoko Bennett, Jeffrey Gould

    Objectives: There is a variation in the incidence of necrotizing enterocolitis (NEC) among countries. To investigate the influence of ethnicity, NEC incidents were compared between Japan and California. Study Design: A retrospective cohort study was conducted using neonatal databases in Japan and California, including infants between 2008 and 2019 at 22-29 gestational weeks. Infants born in Japan (JP) were compared to infants born in California to mothers born in Japan (JP-J), to mothers with Japanese ethnicity born outside Japan (JP-CA), and to non-Hispanic White mothers (NHW-CA). Results: Each cohort consisted of 52,049, 115, 226, and 12,275 infants, respectively. Unadjusted NEC incidences were significantly lower in JP (1.7% vs. 4.4% JP-J+JP-C, and 3.3% NHW-CA, respectively; p<0.01). After background adjustment, odds ratios in JP-J, JP-CA, and NHW-CA vs. JP were 3.0 (1.2-7.8), 2.9 (1.5-5.8), and 2.0 (1.6-2.5), respectively. Conclusions: The NEC incidence variation could not be explained solely based on ethnic background.

  • Open Access

    Dual Mechanism of Action: Exosomes from Human iPSC-Cardiomyocytes and Mesenchymal Stem Cells Restore Injured Myocardium

    by Eileen Tzng, Nathan Bayardo, Gentaro Ikeda, Hiroyuki Takashima, Jennifer Lyons, Mihoko Bennett, Connor Galen O'Brien, Phillip C. Yang

    Background: Transplantation of mesenchymal stem cells or induced pluripotent stem cell derived cardiomyocytes improve heart function after myocardial infarction in pre-clinical models. Exosomes are extracellular vesicles, 30-150nm in size, which regulate the paracrine signal of the stem cells. We investigated the functional outcomes and biological effects of exosomes from pure populations of human bone marrow derived mesenchymal stem cells (MSCs) and induced pluripotent stem cell derived cardiomyocytes (iCMs) in a porcine acute myocardial infarction model. Methods: Yorkshire swine were subject to proximal left anterior descending artery occlusion with a catheter balloon for 1 hour for ischemia-reperfusion injury. Ten 500ul injections containing 5 x 10 11 exosomes isolated from the tissue culture media of iCMs or MSCs were delivered transendocardially into the peri-infarct region. Cardiac function was assessed by magnetic resonance imaging (MRI). Multi-omic analyses were performed in the ex vivo swine peri-infarct specimen to delineate the mechanism of action. Results: Cardiac MRI at weeks 2 and 4 showed significant improvement in heart function in iCM-derived exosomes while MSC-derived exosomes showed a trend towards improvement. A comparative analysis of transcriptomic sequencing of the porcine peri-infarct tissue and Next Generation Sequencing of the exosome cargo confirmed the dual mechanism of action. The marked improvements seen in cardiac function are conferred by miRNA carried by the exosomes, particularly by cardioprotective reduction in metabolism during acute myocardial injury while promoting concurrent cardiomyocyte cell cycle re-entry and proliferation. Conclusions: Significant reduction in myocardial metabolism and increase in proliferation signal pathways were found in both exosome treatment groups; however, distinct sets of microRNAs were found to underlie the mechanism of action in each population of exosomes.

  • Open Access

    28 NICUs participating in a quality improvement collaborative targeting early-onset sepsis antibiotic use

    by Kurlen S. E. Payton, Mihoko V. Bennett, Joseph Schulman, William E. Benitz, Lisa Stellwagen, Gary L. Darmstadt, Jenny Quinn, Alexandria I. Kristensen-Cabrera, Courtney C. Breault, Michael Bolaris, et al.

    Objective: There is widespread overuse of antibiotics in neonatal intensive care units (NICUs). The objective of this study was to safely reduce antibiotic use in participating NICUs by targeting early-onset sepsis (EOS) management. Study design: Twenty-eight NICUs participated in this statewide multicenter antibiotic stewardship quality improvement collaborative. The primary aim was to reduce the total monthly mean antibiotic utilization rate (AUR) by 25% in participant NICUs. Result: Aggregate AUR was reduced by 15.3% (p < 0.001). There was a wide range in improvement among participant NICUs. There were no increases in EOS rates or nosocomial infection rates related to the intervention. Conclusion: Participation in this multicenter NICU antibiotic stewardship collaborative targeting EOS was associated with an aggregate reduction in antibiotic use. This study informs efforts aimed at sustaining improvements in NICU AURs.


  • Quality, outcome, and cost of care provided to very low birth weight infants in California

    by Wannasiri Lapcharoensap, Mihoko Bennett, Xiao Xu, Henry C. Lee, Jochen Profit, Dmitry Dukhovny

    Objective To examine association of costs with quality of care and patient outcome across hospitals in California. Methods Retrospective study of very low birth weight (VLBW) births from 2014–2018 linking birth certificate, hospital discharge records and clinical data. Quality was measured using the Baby-MONITOR score. Clinical outcome was measured using survival without major morbidity (SWMM). Hierarchical generalized linear models, adjusting for clinical factors, were used to estimate risk-adjusted measures of costs, quality, and outcome for each hospital. Association between these measures was evaluated using Pearson correlation coefficient. Results In total, 15,415 infants from 104 NICUs were included. Risk-adjusted Baby-MONITOR score, SWMM rate, and costs varied substantially. There was no correlation between risk-adjusted cost and Baby-MONITOR score (r = 0, p = 0.998). Correlation between risk-adjusted cost and SWMM rate was inverse and not significant (r = −0.07, p = 0.48). Conclusions With the metrics used, we found no correlation between cost, quality, and outcomes in the care of VLBW infants.


  • Does active treatment in infants born at 22–23 weeks correlate with outcomes of more mature infants at the same hospital? An analysis of California NICU data, 2015–2019

    by Shalmali Bane, Matthew A. Rysavy, Suzan L. Carmichael, Tianyao Lu, Mihoko Bennett, Henry C. Lee

    Objective To investigate whether hospital rates of active treatment for infants born at 22–23 weeks is associated with survival of infants born at 24–27 weeks. Study design We included all liveborn infants 22–27 weeks of gestation delivered at California Perinatal Quality Care Collaborative hospitals from 2015 to 2019. We assessed (1) the correlation of active treatment (e.g., endotracheal intubation, epinephrine) in 22–23 week infants and survival until discharge for 24–27 week infants and (2) the association of active treatment with survival using multilevel models. Result The 22–23 week active treatment rate was associated with infant outcomes at 22–23 weeks but not 24–27 weeks. A 10% increase in active treatment did not relate to 24–25 week (adjusted OR: 1.00 [95% CI: 0.95–1.05]), or 26–27 week survival (aOR: 1.02 [0.95–1.09]). Conclusion The hospital rate of active treatment for infants born at 22–23 weeks was not associated with improved survival for 24–27 week infants.